$1.35
0.010.75%
Last update: 3:25 PM
15 minutes delayed
Spero Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Spero Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $-0.33 | $-0.38 | 13.2 % |
Mar 2024 | 2024-05-15 | $-0.24 | $-0.04 | -500.0 % |
Dec 2023 | 2024-03-13 | $0.96 | $-0.10 | 1060.0 % |
Sep 2023 | 2023-11-13 | $-0.06 | $-0.03 | -100.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $10.20M | $3.27M | 211.8 % |
Mar 2024 | 2024-05-15 | $9.27M | $21.53M | -57.0 % |
Dec 2023 | 2024-03-13 | $73.52M | $18.63M | 294.6 % |
Sep 2023 | 2023-11-13 | $25.47M | $14.97M | 70.2 % |
Spero Therapeutics (SPRO) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $-0.33, which beat the estimate of $-0.38.
The Actual Revenue was $10.2M, which beat the estimate of $3.3M.
Browse earnings estimates, EPS, and revenue on all stocks.